The Cancer Genome Atlas Database aims to characterize the changes that occur in genes due to cancer. Knowledge about such changes can be of central nature when aiming to predict the life expectancy as well as the medication or sequence of medication that should be administered to a patient to ensure his/her survival. So far, experts that needed this data had to wait in long data queues and write dedicated tools to analyze this data.